207 related articles for article (PubMed ID: 16632346)
1. Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
Pizer BL; Weston CL; Robinson KJ; Ellison DW; Ironside J; Saran F; Lashford LS; Tait D; Lucraft H; Walker DA; Bailey CC; Taylor RE
Eur J Cancer; 2006 May; 42(8):1120-8. PubMed ID: 16632346
[TBL] [Abstract][Full Text] [Related]
2. Impact of radiotherapy parameters on outcome for patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study.
Taylor RE; Donachie PH; Weston CL; Robinson KJ; Lucraft H; Saran F; Ellison DW; Ironside J; Walker DA; Pizer BL;
Radiother Oncol; 2009 Jul; 92(1):83-8. PubMed ID: 19328574
[TBL] [Abstract][Full Text] [Related]
3. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
[TBL] [Abstract][Full Text] [Related]
4. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
[TBL] [Abstract][Full Text] [Related]
5. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
[TBL] [Abstract][Full Text] [Related]
6. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.
Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Yao MS; Zeltzer PM
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):204-13. PubMed ID: 15337557
[TBL] [Abstract][Full Text] [Related]
7. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor.
Paulino AC; Cha DT; Barker JL; Lo S; Manera RB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1171-6. PubMed ID: 15001261
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
[TBL] [Abstract][Full Text] [Related]
9. Radiation is an important component of multimodality therapy for pediatric non-pineal supratentorial primitive neuroectodermal tumors.
McBride SM; Daganzo SM; Banerjee A; Gupta N; Lamborn KR; Prados MD; Berger MS; Wara WM; Haas-Kogan DA
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1319-23. PubMed ID: 18485615
[TBL] [Abstract][Full Text] [Related]
10. Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials.
Timmermann B; Kortmann RD; Kühl J; Rutkowski S; Meisner C; Pietsch T; Deinlein F; Urban C; Warmuth-Metz M; Bamberg M
J Clin Oncol; 2006 Apr; 24(10):1554-60. PubMed ID: 16575007
[TBL] [Abstract][Full Text] [Related]
11. Non-pineal supratentorial primitive neuro-ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio-spinal irradiation?
Biswas S; Burke A; Cherian S; Williams D; Nicholson J; Horan G; Jefferies S; Williams M; Earl HM; Burnet NG; Hatcher H
Pediatr Blood Cancer; 2009 Jul; 52(7):796-803. PubMed ID: 19202566
[TBL] [Abstract][Full Text] [Related]
12. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Saran F; Walker DA; Pizer BL; Lashford LS; ;
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1184-93. PubMed ID: 15001263
[TBL] [Abstract][Full Text] [Related]
13. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of outcome and prognostic factors in thoracic primitive neuroectodermal tumor: a study of 84 cases.
Biswas B; Agarwala S; Shukla NK; Deo S; Sharma D; Thulkar S; Vishnubhatla S; Bakhshi S
Ann Thorac Surg; 2013 Dec; 96(6):2006-14. PubMed ID: 24035307
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: results of a Children's Cancer and Leukaemia Group study.
Pizer B; Donachie PH; Robinson K; Taylor RE; Michalski A; Punt J; Ellison DW; Picton S
Eur J Cancer; 2011 Jun; 47(9):1389-97. PubMed ID: 21474302
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
17. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
[TBL] [Abstract][Full Text] [Related]
18. A pilot study of risk-adapted radiotherapy and chemotherapy in patients with supratentorial PNET.
Chintagumpala M; Hassall T; Palmer S; Ashley D; Wallace D; Kasow K; Merchant TE; Krasin MJ; Dauser R; Boop F; Krance R; Woo S; Cheuk R; Lau C; Gilbertson R; Gajjar A
Neuro Oncol; 2009 Feb; 11(1):33-40. PubMed ID: 18796696
[TBL] [Abstract][Full Text] [Related]
19. Pineal and nonpineal supratentorial primitive neuroectodermal tumors.
Jakacki RI
Childs Nerv Syst; 1999 Oct; 15(10):586-91. PubMed ID: 10550590
[TBL] [Abstract][Full Text] [Related]
20. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]